PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.

Balance Sheet Ping An Insurance (Group) Company of China, Ltd.

Equities

601318

CNE000001R84

Life & Health Insurance

End-of-day quote Shanghai S.E. Other stock markets 2026-04-17			5-day change	1st Jan Change
57.92 ^CNY	-1.03%		-1.53%	-15.32%

03-26	Ping An Insurance Company of China, Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-26	Ping an Insurance Company of China, Ltd. Proposes Dividend for the Year Ended December 31, 2025, Payable on or About 15 July 2026	CI

26134751ce237fa7.T0jskcjPUJvKxkbuRkLqaxnptOOIsJhnNSaDFgV0vc4.Kym0ouWpAPWylTXZGRHTJHaBg4y618gCUEHwbGMlxZspJYrfmqYI876Bcg

Published financial data: PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Premiums and Annuity Revenues	740B	742B	536B	551B	559B
Total Interest And Dividend Income	200B	215B	87.38B	44.18B	57.5B
Gain (Loss) on Sale of Investments, Total (Rev)	-12.98B	-88.51B	-51.27B	63.17B	48.42B
Non-Insurance Activities Revenues	265B	275B	273B	244B	222B
Other Revenues, Total	79.27B	77.11B	61.2B	61.71B	68.54B
Total Revenues	1,272B	1,220B	907B	964B	956B
Policy Benefits	619B	631B	444B	453B	458B
Policy Acquisition / Underwriting Costs, Total	80.71B	70.38B	-	-	-
Selling General & Admin Expenses, Total	175B	167B	80.21B	80.47B	82.45B
Provision for Bad Debts	242M	-23M	152M	462M	1B
Provision For Loan Losses - (Ins. / REIT / Utility Templates)	-86.47B	-78.9B	-71.94B	-71.28B	-65.36B
Other Operating Expenses	40.07B	37.69B	48.48B	47.59B	43.72B
Non-Insurance Activities Expenses	102B	108B	117B	112B	89.74B
Reinsurance Income Or Expense	-	-	-	-	-
Total Operating Expenses	1,103B	1,093B	762B	764B	741B
Operating Income	169B	128B	145B	199B	215B
Interest Expense, Total	-28.08B	-22.89B	-24.35B	-26.38B	-29.09B
Currency Exchange Gains (Loss)	1.27B	3.34B	120M	380M	618M
Other Non Operating Income (Expenses)	-2.29B	-2.17B	-463M	-2.76B	-1.03B
EBT, Excl. Unusual Items	140B	106B	120B	170B	186B
Gain (Loss) on Sale of Assets	-	-	-	-	-
Asset Writedown	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	140B	106B	120B	170B	186B
Income Tax Expense	17.78B	-1.62B	10.84B	23.76B	27.29B
Earnings From Continuing Operations	122B	107B	109B	147B	158B
Net Income to Company	122B	107B	109B	147B	158B
Minority Interest	-20.18B	-23.66B	-23.61B	-20.13B	-23.52B
Net Income - (IS)	102B	83.77B	85.66B	127B	135B
Net Income to Common Incl Extra Items	102B	83.77B	85.66B	127B	135B
Net Income to Common Excl. Extra Items	102B	83.77B	85.66B	127B	135B
Per Share Items
Net EPS - Basic	5.77	4.8	4.84	7.16	7.68
Basic EPS - Continuing Operations	5.77	4.8	4.84	7.16	7.68
Basic Weighted Average Shares Outstanding	17.61B	17.45B	17.72B	17.69B	17.56B
Net EPS - Diluted	5.72	4.73	4.74	6.99	7.44
Diluted EPS - Continuing Operations	5.72	4.73	4.74	6.99	7.44
Diluted Weighted Average Shares Outstanding	17.77B	17.71B	18.07B	18.11B	18.11B
Normalized Basic EPS	3.81	2.43	2.9	4.89	5.27
Normalized Diluted EPS	3.77	2.4	2.85	4.77	5.11
Dividend Per Share	2.38	2.42	2.43	2.55	2.7
Payout Ratio	46.19	59.19	59.19	44.95	41.59
American Depositary Receipts Ratio (ADR)	2	2	2	2	2
Supplemental Items
EBITDA	178B	140B	158B	211B	226B
EBITA	170B	129B	146B	200B	216B
EBIT	169B	128B	145B	199B	215B
EBITDAR	179B	141B	159B	212B	228B
Total Revenues (As Reported)	1,288B	1,221B	1,032B	1,141B	1,140B
Effective Tax Rate - (Ratio)	12.74	-1.53	9.03	13.94	14.7
Total Current Taxes	26.82B	27.64B	17.7B	25.3B	22.94B
Total Deferred Taxes	-9.04B	-29.26B	-6.86B	-1.54B	4.35B
Normalized Net Income	67.05B	42.48B	51.46B	86.43B	92.47B
Interest on Long-Term Debt	22.51B	20.02B	24.19B	23.54B	19.6B
Supplemental Operating Expense Items
General and Administrative Expenses	175B	167B	80.21B	80.47B	82.45B
Net Rental Expense, Total	1.27B	1.34B	660M	1.71B	1.72B
Imputed Operating Lease Interest Expense	170M	146M	76.58M	210M	213M
Imputed Operating Lease Depreciation	1.1B	1.2B	583M	1.5B	1.5B
Stock-Based Comp., Other (Total)	672M	899M	1.08B	1.01B	1.16B
Total Stock-Based Compensation	672M	899M	1.08B	1.01B	1.16B

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Investment In Debt Securities	374B	418B	2,637B	3,187B	3,231B
Investment In Equity and Preferred Securities, Total	552B	536B	524B	542B	751B
Trading Asset Securities, Total	1,441B	1,643B	1,817B	2,403B	2,727B
Real Estate Owned	86.49B	115B	122B	122B	131B
Mortgage Loans	655B	783B	304B	326B	355B
Policy Loans	178B	189B	-	-	-
Total Other Investments	3,101B	3,442B	1,791B	1,809B	2,018B
Total investments	6,388B	7,127B	7,194B	8,389B	9,213B
Cash And Equivalents	348B	353B	317B	382B	447B
Reinsurance Recoverable - (IS)	43.13B	37.25B	22.22B	26.08B	25.52B
Other Receivables - (Insurance Template)	2,757B	2,948B	3,448B	3,583B	3,668B
Separate Account Assets	36B	23.09B	-	-	-
Gross Property Plant And Equipment	111B	113B	112B	112B	109B
Accumulated Depreciation	-46.65B	-46.72B	-51.35B	-54.97B	-53.94B
Net Property Plant And Equipment	63.94B	66.24B	60.2B	57.13B	55.26B
Goodwill	23.18B	44.06B	44.12B	43.54B	38.13B
Other Intangibles, Total	45.29B	55.35B	54.96B	53.72B	45.35B
Restricted Cash	234B	255B	242B	219B	197B
Other Current Assets, Total	92.98B	87.03B	42.8B	58.39B	66.66B
Deferred Tax Assets Long-Term (Collected)	65.36B	92.85B	101B	122B	115B
Deferred Charges Long-Term	-	-	-	-	-
Other Long-Term Assets, Total	44.87B	48.79B	55.99B	24.09B	28.03B
Total Assets	10,142B	11,137B	11,583B	12,958B	13,898B
Liabilities
Accounts Payable, Total	6.66B	10.35B	8.86B	6.87B	5.79B
Accrued Expenses, Total	138B	195B	185B	248B	305B
Insurance And Annuity Liabilities	3,158B	3,461B	4,160B	4,985B	5,361B
Unpaid Claims	119B	138B	-	-	-
Unearned Premiums	170B	174B	-	-	-
Reinsurance Payable - (BS)	-	-	53M	569M	537M
Current Portion of Long-Term Debt	165B	14.16B	12.72B	26.55B	14B
Current Portion of Leases	6.2B	5.45B	4.3B	4.13B	3.96B
Short-Term Borrowings	250B	397B	335B	558B	728B
Long-Term Debt	1,260B	1,271B	1,308B	1,175B	1,227B
Long-Term Leases	8.01B	7.56B	5.94B	4.67B	4.44B
Separate Account Liability	105B	93.33B	-	-	-
Current Income Taxes Payable	16.25B	16.08B	7.12B	14.97B	11.1B
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	1,093B	1,165B	1,190B	1,199B	1,213B
Unearned Revenue Non Current	6.84B	8.29B	7.11B	7.27B	7.3B
Deferred Tax Liability Non-Current	13.6B	14.22B	14.15B	13.98B	6.65B
Other Non Current Liabilities	2,550B	2,991B	3,116B	3,410B	3,594B
Total Liabilities	9,064B	9,962B	10,354B	11,653B	12,482B
Common Stock, Total	18.28B	18.28B	18.21B	18.21B	18.11B
Additional Paid In Capital	112B	118B	124B	130B	125B
Retained Earnings	683B	723B	765B	850B	940B
Treasury Stock	-9.9B	-11B	-5B	-5B	-
Comprehensive Income and Other	9.32B	10.37B	-2.5B	-64.49B	-82.48B
Total Common Equity	812B	859B	899B	929B	1,000B
Minority Interest	265B	317B	330B	376B	416B
Total Equity	1,078B	1,175B	1,229B	1,305B	1,416B
Total Liabilities And Equity	10,142B	11,137B	11,583B	12,958B	13,898B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	18.13B	18.11B	18.11B	18.11B	18.11B
ECS Total Common Shares Outstanding	18.13B	18.11B	18.11B	18.11B	18.11B
Book Value / Share	44.8	47.42	49.65	51.28	55.25
Tangible Book Value	744B	759B	800B	831B	917B
Tangible Book Value Per Share	41.03	41.93	44.18	45.91	50.64
Total Debt	1,688B	1,695B	1,666B	1,768B	1,978B
Net Debt	1,340B	1,342B	1,349B	1,387B	1,531B
Debt Equivalent Oper. Leases	10.19B	10.76B	5.28B	13.65B	13.72B
Minority Interest, Total (Incl. Fin. Div)	265B	317B	330B	376B	416B
Equity Method Investments, Total	284B	281B	259B	186B	141B
Account Code - Inventory Valuation	6	6	6	6	6
Buildings, Total	43.43B	48.87B	50.28B	53.71B	55.86B
Machinery, Total	26.76B	28.66B	28.04B	26.08B	25.21B
Full Time Employees	356K	344K	289K	273K	259K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	102B	83.77B	85.66B	127B	135B
Depreciation, Depletion & Amortization	14.86B	17.14B	17.29B	15.27B	14.35B
Amortization of Goodwill and Intangible Assets - (CF)	1.04B	1.05B	1.04B	1.04B	1.05B
Total Depreciation, Depletion & Amortization	15.9B	18.19B	18.33B	16.31B	15.4B
Amortization of Deferred Charges, Total	2.52B	2.16B	2.92B	3.26B	2.69B
(Gain) Loss On Sale of Asset - (CF)	-14M	-311M	-563M	-3M	-325M
(Gain) Loss on Sale of Investments - (CF)	49.54B	39.08B	23.27B	-31.3B	19.67B
Total Asset Writedown	14.55B	2.17B	463M	2.76B	1.03B
Provision for Credit Losses	60.42B	65.93B	63.53B	57.93B	56.83B
Provision and Write-off of Bad Debts	242M	-23M	152M	462M	1B
Change in Accounts Receivable	12.85B	2.94B	330M	385B	443B
Reinsurance Recoverable - (CF)	-6.63B	1.88B	-1.33B	-2.46B	-296M
Change In Inventories	-1.17B	706M	1.58B	2.95B	599M
Change In Deferred Taxes	-	-	-	-	-
Change in insurance Reserves / Liabilities	331B	323B	318B	-	-
Change in Other Net Operating Assets (Collected)	-307B	84.76B	-28.05B	-30.64B	202B
Other Operating Activities	-184B	-138B	-124B	-149B	-218B
Cash from Operations	90.12B	486B	360B	382B	659B
Capital Expenditure	-12.19B	-8.87B	-7.81B	-6.68B	-8.36B
Sale of Property, Plant, and Equipment	679M	568M	1.07B	409M	708M
Cash Acquisitions	-366M	-37.62B	-	-	-949M
Divestitures	5.23B	507M	65M	-	9.49B
Investment in Marketable and Equity Securities, Total	-182B	-400B	-310B	-617B	-786B
Net (Increase) Decrease in Loans Originated / Sold - Investing	-16.36B	-10.12B	-	-	-
Other Investing Activities, Total	233B	232B	213B	207B	225B
Cash from Investing	27.93B	-224B	-104B	-416B	-560B
Short Term Debt Issued, Total	-	-	-	157B	231B
Long-Term Debt Issued, Total	1,454B	1,078B	1,172B	988B	971B
Total Debt Issued	1,454B	1,078B	1,172B	1,145B	1,202B
Long-Term Debt Repaid, Total	-1,513B	-1,213B	-1,290B	-1,043B	-1,088B
Total Debt Repaid	-1,513B	-1,213B	-1,290B	-1,043B	-1,088B
Repurchase of Common Stock	-8.08B	-5.54B	-4.45B	-3.54B	-3.88B
Common Dividends Paid	-46.94B	-49.58B	-50.71B	-56.91B	-56.05B
Common & Preferred Stock Dividends Paid	-46.94B	-49.58B	-50.71B	-56.91B	-56.05B
Other Financing Activities, Total	-23.15B	-40.5B	-49.44B	-10.6B	21.31B
Cash from Financing	-136B	-231B	-222B	30.95B	75.39B
Foreign Exchange Rate Adjustments	-3.26B	8.57B	1.92B	1.4B	-2.89B
Net Change in Cash	-21.62B	39.77B	36.27B	-1.43B	171B
Supplemental Items
Cash Interest Paid	45.89B	28.21B	22.38B	17.76B	21.09B
Cash Income Tax Paid (Refund)	26.96B	28.65B	26.66B	17.88B	26.85B
Net Debt Issued / Repaid	-58.24B	-135B	-117B	102B	114B
Levered Free Cash Flow	11.01B	-65.93B	-106B	-390B	-303B
Unlevered Free Cash Flow	28.56B	-51.62B	-90.55B	-373B	-285B
Change In Net Working Capital	83.78B	144B	196B	512B	430B

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	1.07	0.75	0.8	1.01	1
Return on Total Capital	3.88	2.83	3.14	4.17	4.16
Return On Equity %	11.79	9.54	9.05	11.58	11.64
Return on Common Equity	12.9	10.03	9.69	13.85	13.97
Margin Analysis
Gross Profit Margin %	30.18	27.23	30.17	34.01	35.81
SG&A Margin	13.74	13.69	8.84	8.35	8.63
EBITDA Margin %	14	11.45	17.46	21.86	23.68
EBITA Margin %	13.35	10.54	16.08	20.78	22.62
EBIT Margin %	13.26	10.45	15.97	20.68	22.51
Income From Continuing Operations Margin %	9.58	8.8	12.05	15.23	16.56
Net Income Margin %	7.99	6.86	9.45	13.14	14.1
Net Avail. For Common Margin %	7.99	6.86	9.45	13.14	14.1
Normalized Net Income Margin	5.27	3.48	5.67	8.97	9.68
Levered Free Cash Flow Margin	0.87	-5.4	-11.66	-40.46	-31.71
Unlevered Free Cash Flow Margin	2.25	-4.23	-9.98	-38.75	-29.8
Asset Turnover
Asset Turnover	0.13	0.11	0.08	0.08	0.07
Fixed Assets Turnover	20.12	18.75	14.35	16.43	17.01
Receivables Turnover (Average Receivables)	13.87	16.19	-	-	-
Inventory Turnover (Average Inventory)	-	-	-	-	-
Short Term Liquidity
Current Ratio	1.31	1.36	1.75	1.8	1.87
Quick Ratio	1.12	1.18	1.57	1.65	1.74
Operating Cash Flow to Current Liabilities	0.04	0.22	0.21	0.19	0.29
Days Sales Outstanding (Average Receivables)	26.32	22.54	-	-	-
Days Outstanding Inventory (Average Inventory)	-	-	-	-	-
Average Days Payable Outstanding	76.42	84.89	5.58	4.71	4.1
Cash Conversion Cycle (Average Days)	-	-	-	-	-
Long Term Solvency
Total Debt/Equity	156.66	144.25	135.56	135.55	139.67
Total Debt / Total Capital	61.04	59.06	57.55	57.55	58.28
LT Debt/Equity	117.63	108.8	106.91	90.43	86.99
Long-Term Debt / Total Capital	45.83	44.55	45.38	38.39	36.29
Total Liabilities / Total Assets	89.37	89.45	89.39	89.93	89.81
EBIT / Interest Expense	6.01	5.57	5.95	7.55	7.39
EBITDA / Interest Expense	6.57	6.37	6.7	8.17	7.92
(EBITDA - Capex) / Interest Expense	6.14	5.98	6.38	7.92	7.64
Total Debt / EBITDA	9.15	11.63	10.21	8.2	8.58
Net Debt / EBITDA	7.26	9.21	8.27	6.43	6.64
Total Debt / (EBITDA - Capex)	9.79	12.39	10.73	8.47	8.9
Net Debt / (EBITDA - Capex)	7.77	9.81	8.68	6.64	6.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-3.66	-4.14	2.51	6.26	-0.82
Gross Profit, 1 Yr. Growth %	-10.63	-13.73	0.73	19.78	4.42
EBITDA, 1 Yr. Growth %	-20.08	-21.52	-9.28	27.27	7.43
EBITA, 1 Yr. Growth %	-21.21	-24.24	-10.73	30.91	7.91
EBIT, 1 Yr. Growth %	-21.31	-24.4	-10.79	31.12	7.95
Earnings From Cont. Operations, 1 Yr. Growth %	-23.57	-11.8	-18.95	34.28	7.88
Net Income, 1 Yr. Growth %	-28.99	-17.56	-22.83	47.79	6.45
Normalized Net Income, 1 Yr. Growth %	-33.67	-36.65	-21.01	67.95	6.98
Diluted EPS Before Extra, 1 Yr. Growth %	-28.86	-17.31	-24.4	47.47	6.44
Net Property, Plant and Equip., 1 Yr. Growth %	2.38	3.59	-9.12	-5.09	-3.28
Inventory, 1 Yr. Growth %	-	-	-	-	-
Accounts Receivable, 1 Yr. Growth %	-15.07	-9.46	-	-	-
Total Assets, 1 Yr. Growth %	6.45	9.81	5.21	11.87	7.26
Common Equity, 1 Yr. Growth %	6.54	5.7	3.43	3.29	7.73
Tangible Book Value, 1 Yr. Growth %	6.54	2.06	3.92	3.93	10.3
Cash From Operations, 1 Yr. Growth %	-71.12	439.2	-24.41	6.12	72.2
Capital Expenditures, 1 Yr. Growth %	21.92	-27.2	-11.96	-14.49	25.11
Levered Free Cash Flow, 1 Yr. Growth %	-95.05	-595.83	-69.53	268.63	-22.31
Unlevered Free Cash Flow, 1 Yr. Growth %	-88.03	-267.35	-72.8	333.78	-23.74
Dividend Per Share, 1 Yr. Growth %	8.18	1.68	0.41	4.94	5.88
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	0.09	-3.85	-15.6	4.37	2.66
Gross Profit, 2 Yr. CAGR %	-4.17	-12.03	-15.71	9.84	11.84
EBITDA, 2 Yr. CAGR %	-8.76	-20.81	-5.7	9.86	16.93
EBITA, 2 Yr. CAGR %	-9.47	-22.74	-7.3	10.72	18.86
EBIT, 2 Yr. CAGR %	-9.52	-22.87	-7.35	10.79	18.97
Earnings From Cont. Operations, 2 Yr. CAGR %	-13.92	-17.89	-5.28	4.33	20.36
Net Income, 2 Yr. CAGR %	-17.53	-23.49	-8.18	6.8	25.43
Normalized Net Income, 2 Yr. CAGR %	-18.82	-35.18	-12.39	15.18	34.04
Diluted EPS Before Extra, 2 Yr. CAGR %	-17.38	-23.3	-8.97	5.59	25.28
Net Property, Plant and Equip., 2 Yr. CAGR %	0.33	2.98	-2.98	-7.13	-4.19
Inventory, 2 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 2 Yr. CAGR %	-1.58	-12.31	-99.39	-	-
Total Assets, 2 Yr. CAGR %	11.06	8.12	6.87	8.49	9.54
Common Equity, 2 Yr. CAGR %	9.86	6.12	5.2	3.36	5.49
Tangible Book Value, 2 Yr. CAGR %	10.45	4.28	3.69	3.92	7.06
Cash From Operations, 2 Yr. CAGR %	-39.89	24.78	99.98	-10.43	35.18
Capital Expenditures, 2 Yr. CAGR %	-0.1	-5.79	-19.94	-13.24	3.43
Levered Free Cash Flow, 2 Yr. CAGR %	-82.64	-45.52	182.03	5.98	69.26
Unlevered Free Cash Flow, 2 Yr. CAGR %	-71.55	-53.49	71.33	5.91	81.9
Dividend Per Share, 2 Yr. CAGR %	7.75	4.88	1.04	2.65	5.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	5.99	-1.31	-11.76	-8.86	2.61
Gross Profit, 3 Yr. CAGR %	0.79	-7.36	-13.95	-5.24	8.01
EBITDA, 3 Yr. CAGR %	-6.14	-13.23	-10.76	5.76	9.04
EBITA, 3 Yr. CAGR %	-6.84	-14.69	-12.19	5.67	9.78
EBIT, 3 Yr. CAGR %	-6.86	-14.78	-12.26	5.71	9.84
Earnings From Cont. Operations, 3 Yr. CAGR %	0.37	-13.22	-11.82	6.4	5.5
Net Income, 3 Yr. CAGR %	-1.83	-17.54	-15.72	7.6	6.68
Normalized Net Income, 3 Yr. CAGR %	-9.03	-25.26	-20.15	8.83	12.38
Diluted EPS Before Extra, 3 Yr. CAGR %	-1.64	-17.36	-16.15	6.91	5.87
Net Property, Plant and Equip., 3 Yr. CAGR %	12.12	1.4	-1.22	-3.69	-5.86
Inventory, 3 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 3 Yr. CAGR %	5.94	-4.28	-96.86	-	-
Total Assets, 3 Yr. CAGR %	12.4	10.64	6.73	8.51	8.08
Common Equity, 3 Yr. CAGR %	13.44	8.45	5.64	4.56	4.8
Tangible Book Value, 3 Yr. CAGR %	13.66	7.58	4.63	3.77	6
Cash From Operations, 3 Yr. CAGR %	-24.12	24.89	4.92	61.91	11.37
Capital Expenditures, 3 Yr. CAGR %	4.55	-10.1	-7.89	-18.17	-1.98
Levered Free Cash Flow, 3 Yr. CAGR %	-57.66	-43.49	-21.91	208.36	-4.43
Unlevered Free Cash Flow, 3 Yr. CAGR %	-37.72	-47.3	-27.61	129.61	-5.07
Dividend Per Share, 3 Yr. CAGR %	11.43	5.69	3.37	2.33	3.72
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	10.37	4.53	-3.22	-5.36	-6.25
Gross Profit, 5 Yr. CAGR %	7.28	0.99	-6.1	-4.74	-4.44
EBITDA, 5 Yr. CAGR %	9.63	-2.25	-5.96	-0.31	0.31
EBITA, 5 Yr. CAGR %	9.38	-3.16	-7.03	-0.66	0.07
EBIT, 5 Yr. CAGR %	9.52	-3.13	-7.06	-0.67	0.07
Earnings From Cont. Operations, 5 Yr. CAGR %	10.97	1.45	-1.93	-2.24	-0.13
Net Income, 5 Yr. CAGR %	10.25	-1.22	-4.42	-3.26	-1.19
Normalized Net Income, 5 Yr. CAGR %	6.46	-10.34	-10.39	-3.21	-1.77
Diluted EPS Before Extra, 5 Yr. CAGR %	10.39	-1.06	-4.64	-3.56	-1.54
Net Property, Plant and Equip., 5 Yr. CAGR %	9.76	7.07	5.82	-2.1	-2.42
Inventory, 5 Yr. CAGR %	-	-	-	-	-
Accounts Receivable, 5 Yr. CAGR %	17.71	9.61	-86.55	-	-
Total Assets, 5 Yr. CAGR %	12.71	11.39	10.15	9.52	7.84
Common Equity, 5 Yr. CAGR %	16.2	12.65	10.07	6.65	5.58
Tangible Book Value, 5 Yr. CAGR %	18.35	12.99	9.57	6.39	5.6
Cash From Operations, 5 Yr. CAGR %	-16.93	31.99	11.81	8.92	16.11
Capital Expenditures, 5 Yr. CAGR %	-6.02	-14.36	-6.04	-11.37	-3.52
Levered Free Cash Flow, 5 Yr. CAGR %	-47.09	-9.36	-6.11	1.31	6.41
Unlevered Free Cash Flow, 5 Yr. CAGR %	-36.39	-12.15	-5.2	1.14	3.6
Dividend Per Share, 5 Yr. CAGR %	25.98	10.04	7.16	4.46	4.18